Yaowei Zhu

A Phase I Study Evaluating the Safety, Pharmacokinetics, and Clinical Response of a Human IL-12 p40 Antibody in Subjects with Plaque Psoriasis

Catharine Lisa Kauffman, Nancy Aria, Eiko Toichi et al. · Journal of Investigative Dermatology · 2004 · 275 citations

Clinical Immunology, Medicine, Immunology +8

Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study

Ian Landells, Colleen Marano, Ming-Chun Hsu et al. · Journal of the American Academy of Dermatology · 2015 · 220 citations · Full text

Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL‐12/23p40, in Patients With Moderate to Severe Plaque Psoriasis

Yaowei Zhu, Chuanpu Hu, Ming Lu et al. · The Journal of Clinical Pharmacology · 2009 · 166 citations

Rheumatoid Disorder, Autoimmune Disease, Medicine +13

Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: Rationale for dosing recommendations

Mark Lebwohl, Newman Yeilding, Philippe Szapary et al. · Journal of the American Academy of Dermatology · 2010 · 128 citations

Medicine, Severe Psoriasis, Clinical Dermatology +3

Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial

Arthur Kavanaugh, L. Puig, Alice B. Gottlieb et al. · Arthritis Care & Research · 2015 · 105 citations · Full text